Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

Contineum Therapeutics (CTNM) Interest Expenses (2023)

Historic Interest Expenses for Contineum Therapeutics (CTNM) over the last 1 years, with Q2 2023 value amounting to $116000.0.

  • Contineum Therapeutics' Interest Expenses changed N/A to $116000.0 in Q2 2023 from the same period last year, while for Mar 2024 it was $116000.0, marking a year-over-year change of. This contributed to the annual value of $208000.0 for FY2023, which is N/A changed from last year.
  • As of Q2 2023, Contineum Therapeutics' Interest Expenses stood at $116000.0.
  • In the past 5 years, Contineum Therapeutics' Interest Expenses ranged from a high of $116000.0 in Q2 2023 and a low of $92000.0 during Q1 2023